|国家预印本平台
首页|不同粒度的羧甲基壳聚糖银噻苯咪唑复合抗菌剂的抑菌性能研究

不同粒度的羧甲基壳聚糖银噻苯咪唑复合抗菌剂的抑菌性能研究

Study on antimicrobial Activity of complex agents Ag-Carboxymethyl Chitosan-thiabendazole with different size distribution

中文摘要英文摘要

为增加固体制剂的水溶性以及考查研磨后其抗菌性能的变化,制备了低含量银和噻苯咪唑的羧甲基壳聚糖银噻苯咪唑(Ag-CMCTS-TBZ)复合抗菌剂,并通过研磨和粒度分级工艺实验将其分成150-74μm、74-45μm和-45μm的C1、C2、C3三种制剂。粒度分析、紫外、红外光谱及最小抑菌浓度(MIC)分析表明,低含量银和噻苯咪唑的Ag-CMCTS-TB都具有良好的水溶性,三种制剂的溶解度都大于0.4%,其0.2%(w/v)的抗菌水溶液中的表观粒度在约13-250nm之间;但在研磨分级之后,三种制剂中分子间的络合或者氢键键合状况发生了变化,而且导致其抗菌性能发生改变;其中C1对E. coli的MIC为400 mg/L,对S. aureus的MIC为800 mg/L,而其抑制A. niger的能力较弱;C3抗菌活性则显著降低,对E. coli、S. aureus、C. albicans和A. niger的MIC值皆>1000 mg/L;C2的抗菌效果则介于其间。

o increase the solubility and trace its variation in antimicrobial activity after powdering process, Ag-Carboxymethyl Chitosan-thiabendazole (Ag-CMCTS-TBZ) with low concentration of Ag+ and thiabendazole (TBZ) was prepared and powdered into three agents with size distribution of 150-74μm、74-45μm and -45μm by standard sieves separating system and marked with C1, C2 and C3 respectively. Particle size analysis shows the apparent diameter of the three agents varies from 13-250 nm or so and all possess good solubility of higher than 0.4%. FT-IR and UV spectroscopy show that binding among Ag+ and TBZ to the skeleton of CMCTS changed under the powdering process and led to decreasing in antimicrobial activity. The minimum inhibitory concentration (MIC) assessment shows C1 presented the best antimicrobial activity with MICs of 400, 800mg/L to E. coli and S. aureus respectively but with poorer performance to A. niger. The antimicrobial activity of C2 is secondary to C1 and and C3 presented the worst antimicrobial performance with MICs all higher than 1000 mg/L for all microbes in test.

夏金兰、吴川、宋廷二、聂珍媛

药学微生物学分子生物学

复合抗菌剂羧甲基壳聚糖银噻苯咪唑最小抑菌浓度粒度

complex antimicrobial agentsAg-carboxymethyl-thiabendazoleminimum inhibitory concentrationsize

夏金兰,吴川,宋廷二,聂珍媛.不同粒度的羧甲基壳聚糖银噻苯咪唑复合抗菌剂的抑菌性能研究[EB/OL].(2006-05-05)[2025-08-16].http://www.paper.edu.cn/releasepaper/content/200605-34.点此复制

评论